Skip to main content

Table 2 Dietary intake and physical activity of the participants throughout the study

From: Effect of soy isoflavones supplementation on migraine characteristics, mental status and calcitonin gene-related peptide (CGRP) levels in women with migraine: results of randomised controlled trial

Variable

Soy isoflavones group

(n = 44)

Placebo group

(n = 44)

P a

Energy (kcal/day)

2215.9 ± 410/77

2367.13 ± 394.35

0.080

Carbohydrate (g/day)

347.75 ± 79.00

358.95 ± 75.76

0.372

Protein (g/day)

78.07 ± 20.99

81.36 ± 17.18

0.499

Fat (g/day)

67.67 ± 15.22

73.06 ± 13.85

0.098

Vitamin A (μg/day)

473.89 ± 313.73

499.65 ± 267.12

0.678

Vitamin D (μg/day)

1.16 ± 0.88

0.99 ± 0.46

0.251

Vitamin E (mg/day)

14.08 ± 5.87

13.73 ± 5.25

0.802

Vitamin C (mg/day)

106.23 ± 79.28

79.12 ± 11.04

0.458

Thiamin (mg/day)

1.89 ± 0.52

1.97 ± 0.46

0.409

Riboflavin (mg/day)

1.70 ± 0.51

1.90 ± 0.51

0.078

Niacin (mg/d)

23.58 ± 3.81

24.64 ± 4.9

0.213

Cobalamin (μg/day)

34.53 ± 11.48

37.13 ± 13.37

0.330

Magnesium (mg/day)

232.25 ± 104.55

215.48 ± 77.95

0.982

Physical activity (MET/h/day)

24.13 ± 5.2

23.11 ± 6.36

0.412

  1. Variables are expressed as mean ± SD
  2. a Obtained from independent t test
  3. MET Metabolic equivalent task